Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Similar documents
The Emerging Science of E-Cigarette Use and Nicotine Addiction

Public Health Approaches to Substance Misuse and Addictions

ASTHO President s Challenge 15 x 15: Reduce Prescription Drug

End the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN

Successful Prevention Strategies to Address the Opioid Crises

OPIOIDS IN JACKSON COUNTY A PUBLIC HEALTH PERSPECTIVE OPIOID AWARENESS COUNTY LEADERSHIP FORUM SHELLEY CARRAWAY, HEALTH DIRECTOR DATE

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Association of State and Territorial Health Officials (ASTHO)

September 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201

Safe States Alliance 2018 Innovative Initiatives Finalist Summaries for Review

Tom Williams, MD Chief Medical Officer Director of the Division of Public Health Nebraska Department of Health and Human Services

Addressing the Opioid Epidemic in Tennessee

State Action to Prevent and

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

Opioid Overdose in Oregon Report to the Legislature

Module 6: Substance Use

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

SAMHSA State/Tribal/Adolescents at Risk Suicide Prevention Grantee Technical Assistance Meeting

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health

Prescription Opioid Overdose in Oregon: A public health perspective

Data-Driven Prevention Initiative

Washington State PMP Data Mapping Project

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C

Best Practices and Foundation Forum. Fred Wells Brason II

Community Response Addressing The Opioid Crisis. Leon, Wakulla, Gadsden, Franklin, Liberty, Jefferson, Madison and Taylor Counties

COMMUNITY ASSESSMENT OF THE OPIOID CRISIS IN LORAIN COUNTY, OHIO EXECUTIVE SUMMARY

What is the strategy?

Opioid Data for Local Governments in North Carolina

The Opioid Addiction Emergency In Virginia June 8, 2017

Intervention from the World Health Organization

OPIOID INITIATIVE SMART GOALS AND OBJECTIVES Four Pillar Approach

Michael M. Miller, MD, FASAM, FAPA

Decriminalization of Personal Use of Psychoactive Substances

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

Suicide Prevention Strategic Plan

Public Health Federal Funding Request to Address the Opioid Epidemic

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Rural Prevention and Treatment of Substance Abuse Toolkit

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Strategies for Federal Agencies

A Drug Policy for the 21st Century

Opioid Overview Admiral Brett P. Giroir, M.D.

National Strategies for Local Solutions

Community Health Priority: Alcohol & Other Drug Misuse and Abuse

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

May 25, Drug Overdose Update & Response: Combatting Opioid Overdose

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

OVERVIEW. NCHRC Harm Reduction Pills Ingestion to Smoking/Injecting Harm Reduction Legislation, Services and Advocacy Ban the Box/Fair Hiring LEAD Q+A

Coalition Strategies Across The Continuum of Care

The Prescription Opioid and Heroin Crisis

CDC s Efforts to End the Opioid Epidemic

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

Understanding the Opiate Epidemic

Getting to Zero Alcohol- Impaired Driving Fatalities: A Comprehensive Approach to a Persistent Problem

The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2019 Budget and Appropriations

Understanding the Opioid Crisis: What s at the Heart of the Matter?

National Viral Hepatitis Action Plan Priority Populations Approach

Meth and Opioid Abuse Prevention Efforts

Reducing opioid overdose mortality: role of communityadministered

Substance Use Disorders: A Path Forward for Michigan

What do we mean by the opioid crisis? Painkiller prescriptions per 100 North Carolinians Source: CDC US Prescribing Rate Maps (2016)

DPH Priorities and Statewide Initiatives

ACCG Mental Health Summit

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

Substance Abuse Trends in Maine Epidemiological Profile 2013

Historical Perspectives

FY2018 Labor, Health and Human Services, Education Appropriations Summary

From Opioid Overdose Prevention to Community Resilience CAPT Jeffrey Coady, Psy.D., ABPP SAMHSA Regional Administrator (Region 5)

Opioid Epidemic as it Relates to Counties

Substance use and misuse

Addiction and Substance misuse pathways

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

FY2019 Labor, Health and Human Services, Education Appropriations Summary

Comprehensive Substance Abuse Strategic Action Plan

Wednesday, June 21, Dear Chairmen and Ranking Members:

PDMP Track: Linking and Mapping PDMP Data. Gillian Leichtling Acumentra Health Chris Baumgartner, WA State Dept. of Health

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

High-Decile Prescribers: All Gain, No Pain?

National Academy of Medicine Action Collaborative: Countering the US Opioid Epidemic

Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs

The Legalization of Cannabis through a Health Equity Lens

Mental and Behavioral Health

Substance Abuse Trends in Maine. Epidemiological Profile Central District

INGHAM OPIOID ABUSE PREVENTION INITIATIVE STRATEGIC PLAN PREPARED BY: INGHAM COUNTY HEALTH DEPARTMENT

2017 Washington State Interagency Opioid Working Plan

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Collaborative for Effective Prescription Opioid Policies

FY19 Labor, Health and Human Services, and Education Appropriations Bill

FDA s Response to the Opioid Crisis and the FDA Safe Use Initiative

OPIOID WORKGROUP LEADERSHIP TEAM

By Richard Harris, Assistant Director. May 21, 2010

Opportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths

Decriminalization of Personal Use of Psychoactive Substances

Kansas Prescription Drug and Opioid Advisory Committee

Transcription:

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health and Social Services, Director, Alaska Div of Public Health Anne Schuchat, MD, Principal Deputy Director Centers for Disease Control and Prevention Terry Cline, PhD, Commissioner of Health and Secretary of Health and Human Services, Oklahoma State Department of Health Umair A. Shah, MD, MPH, Executive Director, Harris County Public Health & Environmental Services Kara Nelson, Director, Haven House Juneau

2017 President s Challenge Jay C. Butler, MD, CPE Chief Medical Officer, Alaska Department of Health and Social Services Director, Division of Public Health

A Web of Cause and Effect LIMITED ACCESS TO CARE HIV, SEXUALLY TRANSMITTED INFECTIONS, VIRAL HEPATITIS SELF-HARM AND INTERPERSONAL VIOLENCE LOW EDUCATIONAL ATTAINMENT POVERTY MENTAL ILLNESS SUBSTANCE MISUSE AND ADDICTIONS SOCIAL ISOLATION HUMAN TRAFFICKING IMPRISONMENT ADVERSE AND HISTORIC TRAUMA CHILDHOOD EXPERIENCES OTHER FACTORS RECIDIVISM

2017 Challenge: Public Health Approaches to Preventing Substance Misuse and Addictions 46

Building on Past Challenges Injury Prevention Healthy Babies Prescription Drug Abuse Advancing Health Equity and Optimal Health for All 2009 2010 2011 2012 2013 2014 2015 2016 2017 Walk the Talk Promoting Health Equity Reintegration of Public Health and Healthcare Healthy Aging

Scope of Substance Misuse and Addictions Legal Substances Alcohol, Marijuana Illicit Substances Heroin, Methamphetamines, Synthetic Cannabinoids, Cathinones Therapeutic Substances and Prescription Drugs Opioids, Amphetamines, Benzodiazepines Emerging Technologies Powdered Alcohol, Vaping Devices, Designer Psychoactives

Substance Misuse in the United States Overdose is the leading cause of injury-related death in the United States. 1 in 10 Americans aged 12 or older used illicit drugs in the past month. Past Year Substance Use Disorder Total = 20.8 Million People 3.8 million young adults aged 18 to 25 reported heavy alcohol use in the past month. From 2002 to 2014, the prevalence of daily or almost daily marijuana use in the past year increased by 92 percent. Misuse of tobacco, alcohol, and illicit drugs costs more than $700 billion annually. Source: National Survey on Drug Use and Health, 2015

Substance Misuse and Addictions: Prevention Framework

2016-2019 Strategic Map Develop and Leverage Public Health Approaches to Prevent Substance Misuse, Addictions, and Related Consequences Reduce Stigma and Change Social Norms Increase Protective Factors and Reduce Risk Factors in Communities Strengthen Multi-Sectoral Collaboration Strengthen Prevention Infrastructure Optimize the Use of Cross-Sector Data for Decisionmaking F o s t e r C u l t u r a l C o m p e t e n c e a n d R e l e v a n c e

Cross-Sectoral Collaboration is Key Public Health Agencies Attorneys General Offices Justice and Corrections Medical Boards Healthcare Providers Hospitals and Clinics Community Coalitions Businesses and Labor Media Emergency Medical Services Social Services Agencies Faith Communities Pharmaceutical Industry Educators Third-Party Payers Others

What Can We Do? Increase access to naloxone Provide public and professional education on administering naloxone and managing overdose Eliminate liability and financial barriers Authorize standing orders, third-party prescribing, and pharmacist independent dispensing Support clean needle use End drug paraphernalia laws that restrict access Support syringe and needle sales and exchange programs Reduce impaired driving Support widespread and sustained use of ignition interlocks Implement sobriety checkpoints 53

What Can We Do? Reframe addictions Promote a science-based understanding of addictions Increase awareness of addictions as chronic health conditions Increase screening and diagnosis Incorporate Screening, Brief Intervention and Referral to Treatment (SBIRT) into healthcare and social services Improve access to withdrawal symptom management and support for recovery Remove barriers to access to therapy for withdrawal symptom management and maintenance of recovery Train prescribers and dispensers on identifying and managing addictions Increase facilities and providers Encourage third-party payer coverage 54

What Can We Do? Promote healthy families and increase resiliency Promote maternal and early childhood health programs Prioritize pregnant women for screening and access to treatment Utilize tools outlined in CDC s 2016 technical package, Preventing Child Abuse and Neglect Reduce the prescription supply of opioids in communities Develop and utilize user-friendly, robust PDMPs Support safer pain management and judicious prescribing Expand public and professional education, including evidence-based pain management guidelines and non-opioid pain management strategies Encourage providers to take the Surgeon General s pledge Develop and promote safe medication storage practices and drug return programs 55

What Can We Do? Use data for assessing the problem and measuring progress Standardize and enhance post-mortem toxicological testing in investigation of suspected overdose and suicide deaths (e.g., testing for fentanyl) Leverage Violent Deaths Reporting System to increase timeliness and accuracy of data collection and analysis Develop syndromic surveillance methodology to identify clusters of overdose and substance toxicity Increase capacity to determine risk factors for HCV infection Establish access to and capacity to analyze PDMP data Utilize BRFSS module assessing ACEs Create lines of communication to assure cross-sectoral data sharing 56

What Will Success Look Like? Near horizon (next 3 years) Reduced deaths from drug overdose Declines in motor vehicle crashes from impaired driving Fewer self-injection related HIV and HCV infections Less unintentional injuries and self-harm related to drugs and alcohol Further horizons Lower rates of drug misuse and addiction, including underage use Reduced drug- and alcohol-related incarceration and re-incarceration of persons with addictions Lower rates of crime and referrals to child protective services Less interpersonal violence, self-harm, and child neglect Prevention of excessive prescriptions for controlled substances while improving wellness and function 57

2017 Challenge: Thank you! Public Health Approaches to Preventing Substance Misuse, Addiction, and Related Consequences